Skip to content

Neurobiological Correlates and Predictors of Psychotherapeutic Processes in Patients with OCD

Neurobiological Correlates and Predictors of Psychotherapeutic Processes in Patients with OCD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000290
Enrollment
70
Registered
2009-12-22
Start date
2003-12-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F42

Interventions

Group 1: Cognitive-behavioral therapy (CBT) with in-vivo exposure and response prevention

Sponsors

Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Schleswig-Holstein Campus Lübeck
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - OCD diagnosis according to DSM-IV (SCID) - Y-BOCS total score of 16 or more - Illness duration of at least one year - Absence of psychoactive medication (at least 4 weeks wash-out) - Right handedness (according to EHI)

Exclusion criteria

Exclusion criteria: - Concurrent major depression - Acute Suicidality - Substance abuse or dependence (present and history of) - History of major head trauma - Major neurological and somatic illnesses - Pregnancy and lactation - Absence of contraception in fertile women - Concurrent participation in other clinical trials, including 30 days before enrollment - Generally accepted exclusion criteria for participation in MRI research (http://www.ismrm.org)

Design outcomes

Primary

MeasureTime frame
-Symptom Reduction (Yale-Brown-Obsessive-Compulsive Scale; Clinical Global Impression) - Cognitive Performance (Neuropsychological Test Battery) at T0 and T2 - Concentration of neurometabolites in the brain tissue (Proton Magnetic Resonance Spectroscopy; 1H-MRS) at T0 and T2 - Fractional Anisotropy of white matter of the brain (Diffusion Tensor Imaging; T0 and T2) - BOLD-Signal as measured with functional Magnetic Resonance Imaging (fMRI) during cognitive activation and rest

Secondary

MeasureTime frame
Change of depressive symptoms (Hamilton Depression Rating Scale and Beck Depression Inventory, at timepoints T0 and T2)

Countries

Germany

Contacts

Public ContactAndreas Kordon

Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Schleswig-Holstein Campus Lübeck

andreas.kordon@psychiatrie.uk-sh.de0451-5002982

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026